Literature DB >> 33723235

NIK promotes metabolic adaptation of glioblastoma cells to bioenergetic stress.

Michael L Kamradt1,2, Ji-Ung Jung1,2,3, Kathryn M Pflug1,4, Dong W Lee1, Victor Fanniel1,4, Raquel Sitcheran5,6,7.   

Abstract

Cancers, including glioblastoma multiforme (GBM), undergo coordinated reprogramming of metabolic pathways that control glycolysis and oxidative phosphorylation (OXPHOS) to promote tumor growth in diverse tumor microenvironments. Adaptation to limited nutrient availability in the microenvironment is associated with remodeling of mitochondrial morphology and bioenergetic capacity. We recently demonstrated that NF-κB-inducing kinase (NIK) regulates mitochondrial morphology to promote GBM cell invasion. Here, we show that NIK is recruited to the outer membrane of dividing mitochondria with the master fission regulator, Dynamin-related protein1 (DRP1). Moreover, glucose deprivation-mediated metabolic shift to OXPHOS increases fission and mitochondrial localization of both NIK and DRP1. NIK deficiency results in decreased mitochondrial respiration, ATP production, and spare respiratory capacity (SRC), a critical measure of mitochondrial fitness. Although IκB kinase α and β (IKKα/β) and NIK are required for OXPHOS in high glucose media, only NIK is required to increase SRC under glucose deprivation. Consistent with an IKK-independent role for NIK in regulating metabolism, we show that NIK phosphorylates DRP1-S616 in vitro and in vivo. Notably, a constitutively active DRP1-S616E mutant rescues oxidative metabolism, invasiveness, and tumorigenic potential in NIK-/- cells without inducing IKK. Thus, we establish that NIK is critical for bioenergetic stress responses to promote GBM cell pathogenesis independently of IKK. Our data suggest that targeting NIK may be used to exploit metabolic vulnerabilities and improve therapeutic strategies for GBM.

Entities:  

Year:  2021        PMID: 33723235      PMCID: PMC7960998          DOI: 10.1038/s41419-020-03383-z

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  53 in total

Review 1.  The phosphorylation state of Drp1 determines cell fate.

Authors:  Arezu Jahani-Asl; Ruth S Slack
Journal:  EMBO Rep       Date:  2007-10       Impact factor: 8.807

Review 2.  NF-κB inducing kinase: a key regulator in the immune system and in cancer.

Authors:  Yee Mon Thu; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-03       Impact factor: 7.638

3.  NIK/MAP3K14 Regulates Mitochondrial Dynamics and Trafficking to Promote Cell Invasion.

Authors:  Ji-Ung Jung; Sowndharya Ravi; Dong W Lee; Kassandra McFadden; Michael L Kamradt; L Gerard Toussaint; Raquel Sitcheran
Journal:  Curr Biol       Date:  2016-11-23       Impact factor: 10.834

Review 4.  The non-canonical NF-κB pathway in immunity and inflammation.

Authors:  Shao-Cong Sun
Journal:  Nat Rev Immunol       Date:  2017-06-05       Impact factor: 53.106

5.  Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.

Authors:  Natalya V Guseva; Agshin F Taghiyev; Mary T Sturm; Oskar W Rokhlin; Michael B Cohen
Journal:  Mol Cancer Res       Date:  2004-10       Impact factor: 5.852

6.  Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells.

Authors:  Rodrigue Rossignol; Robert Gilkerson; Robert Aggeler; Kunihiro Yamagata; S James Remington; Roderick A Capaldi
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

7.  Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells.

Authors:  Hidenori Otera; Chunxin Wang; Megan M Cleland; Kiyoko Setoguchi; Sadaki Yokota; Richard J Youle; Katsuyoshi Mihara
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

8.  Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth.

Authors:  Sarbajeet Nagdas; Jennifer A Kashatus; Aldo Nascimento; Syed S Hussain; Riley E Trainor; Sarah R Pollock; Sara J Adair; Alex D Michaels; Hiromi Sesaki; Edward B Stelow; Todd W Bauer; David F Kashatus
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

Review 9.  Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer.

Authors:  Kathryn M Pflug; Raquel Sitcheran
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

10.  The mitochondrial fission receptor Mff selectively recruits oligomerized Drp1.

Authors:  Raymond Liu; David C Chan
Journal:  Mol Biol Cell       Date:  2015-10-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.